Are PNETs radiotherapy resistant?

References (7)

1. Saif MW, Ove R, Ng J, Russo S. Radiotherapy in the management of pancreatic neuroendocrine tumors (PNET ): experience at three insti-tutions. Anticancer Res 2013
2. 33 (5): 2175-7. [CrossRef ] 2. Contessa JN, Griffith KA, Wolff E, Ensminger W, Zalupski M, Law-rence TS, et al. Radiotherapy for pancreatic neuroendocrine tumors. Int J Radiat Oncol Biol Phys 2009
3. 75 (4): 1196-200. doi: 10.1016/j.ijrobp.2008.12.044. Epub 2009 Mar 26. [CrossRef ] 3. Iwata T, Ueno H, Itami J, Ito Y, Inaba K, Morizane C, et al. Efficacy of radiotherapy for primary tumor in patients with unresectable pancre-atic neuroendocrine tumors. Jpn J Clin Oncol 2017
4. 47 (9): 826-31. doi: 10.1093/jjco/hyx081. [CrossRef ] 4. Zagar TM, White RR, Willett CG, Tyler DS, Papavassiliou P, Papalezo-va KT, et al. Resected pancreatic neuroendocrine tumors: patterns of failure and disease-related outcomes with or without radiothera-py. Int J Radiat Oncol Biol Phys 2012
5. 83 (4): 1126-31. doi: 10.1016/j.ijrobp.2011.09.041. Epub 2012 Jan 21. [CrossRef ] 5. Arvold ND, Willett CG, Fernandez-del Castillo C, Ryan DP, Ferrone CR, Clark JW, et al. Pancreatic neuroendocrine tumors with involved sur-gical margins: prognostic factors and the role of adjuvant radiother-apy. Int J Radiat Oncol Biol Phys 2012
6. 83 (3): e337-43. doi: 10.1016/j.ijrobp.2011.12.068. Epub 2012 Mar 11. [CrossRef ] 6. Maidment BW, Ellison T, Herman JM, Sharma NK, Laheru D, Regine W, et al. Radiation in the management of pancreatic neuroendocrine tumors. J Clin Oncol 2012
7. 30 (Suppl 4): S335. [CrossRef